-+ 0.00%
-+ 0.00%
-+ 0.00%

William Blair Downgrades Evommune to Market Perform

Benzinga·06/29/2026 16:52:05
Listen to the news
William Blair analyst Matt Phipps downgrades Evommune (NYSE:EVMN) from Outperform to Market Perform.